An agreement is signed between and to improve treatment capacity and the quality of medical care for lung cancer patients in central Vietnam. (Photo: VNA)Da Nang (VNA) – Da Nang Oncology Hospital and the UK’s AstraZeneca Vietnam on March 12 signed an agreement to improve treatment
capacity and the quality of medical care for lung cancer patients, targeting those in central
Vietnam.
Under the agreement, the two sides will cooperate in conducting
clinical studies of cancer, developing and implementing programmes in training
for medical workers and patients’ support delivery; and promoting international
cooperation in oncology.
Director of the Da Nang Oncology Hospital Tran Tu Quy said
the deal will help comprehensively enhance capacity in cancer screening and
treatment and benefit patients in not only Da Nang but also surrounding areas.
On this occasion, the two sides partnered in the programme “Vietnam
Healthy Lung” between 2021 – 2023, aimed at raising the quality of respiratory
disease management in Vietnam. The programme has entered the second phase with
expansion into the field of .
It is estimated that over 4.2 percent of Vietnam’s population
suffers from Chronic Obstructive Pulmonary Disease. It is worrying that most of
them are not currently diagnosed due to a lack of medical facilities, poor
awareness of patients and limitations in the professional skills of public
health, according to the health ministry.
Vietnam each year reported about 23,667 new lung cancer
cases and 20,170 deaths. Most people with cancer in Vietnam visit hospitals for
medical examination and treatment in a late stage, making treatment difficult
and creating a huge financial burden on patients./.
Source: VietnamPlus
